Form 8-K MCKESSON CORP For: Sep 05

Go back to Form 8-K MCKESSON CORP For: Sep 05

McKesson (MCK) PT Lowered to $665 at Leerink Partners

September 6, 2024 6:36 AM EDT

Leerink Partners analyst Michael Cherny lowered the price target on McKesson (NYSE: MCK) to $665.00 (from $670.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: Since last earnings, MCK has certainly muddied the waters for what had primarily been a straightforward beat-and-raise story. The... More

McKesson (MCK) Declines After Issuing Soft Second Quarter EPS Guidance

September 5, 2024 12:08 PM EDT

(Updated - September 5, 2024 12:08 PM EDT)

McKesson (NYSE: MCK) disclosed:


McKesson Corporation participated in the Wells Fargo 2024 Healthcare Conference on September 5, 2024, as previously noticed in the companys August 7, 2024 earnings release and on its investor relations website investor.mckesson.com.


During the... More